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OBJECTIVES This study reports a comparative assessment of the hemodynamic relevance of myocardial
bridges (MB) using two modalities of fractional flow reserve (FFR), with and without
concomitant inotropic challenge.
BACKGROUND Extravascular coronary compression by means of MB is modulated by myocardial inotropism
and causes intracoronary systolic pressure overshooting and negative systolic gradients across
the MB. The former characteristic suggests that adequate hemodynamic assessment of MB
should include inotropic stimulation. The latter characteristic might interfere with FFR by
decreasing the mean pressure gradient.
METHODS We compared the hemodynamic relevance of 12 lone MB in symptomatic patients using
conventional (mean) and diastolic FFR. Diastolic FFR was obtained from post-processed,
digitally acquired electrocardiogram and pressure signals. Previously validated cut off values of
0.75 (mean FFR) and 0.76 (diastolic FFR) for hemodynamic relevance were used. Measure-
ments were performed at baseline and after incremental intravenous dobutamine doses.
RESULTS Fractional flow reserve decreased during dobutamine challenge: mean FFR was 0.90  0.04
at baseline and 0.84  0.06 after dobutamine (p  0.0008); similarly, diastolic FFR was 0.88
 0.05 and 0.77  0.10 before and after dobutamine, respectively (p  0.0006). Diastolic
FFR identified hemodynamic relevance in five patients, whereas mean FFR did so in only one
patient. The discrepancy between mean FFR and diastolic FFR increased with dobutamine
challenge: the ratio of mean FFR/diastolic FFR was 1.03 at baseline and 1.09 after
dobutamine (p  0.02). During the administration of dobutamine, the discrepancy was
inversely related to the systolic pressure gradient (r  0.58, p  0.04).
CONCLUSIONS Physiologic assessment of MB should include dobutamine challenge. Because the overshoot-
ing of systolic pressure interferes with and is a cause of error in FFR measurements based on
mean pressures, diastolic FFR appears to be the technique of choice for MB assessment,
whereas mean FFR should be used with caution. (J Am Coll Cardiol 2003;42:226–33)
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Although myocardial bridges (MB) are commonly found in
normal human hearts (1,2), their association with anginal
chest pain or abnormal noninvasive tests often constitutes a
important clinical issue. Myocardial bridges have been
associated with stable and variant angina, sudden death, and
myocardial infarction (1–10), a variety of coronary syn-
dromes with the twofold substrate of the disturbed coronary
hemodynamics (9), and endothelial dysfunction (11) caused
by extravascular vessel compression. Although surgical
treatment of MB was seldom performed (12), the wide-
spread use of coronary stenting has led to a more aggressive
treatment approach of MB (9,13–20). Although stenting
can be hemodynamically effective in MB (9,19), the avail-
ability and ease of coronary stenting probably constitute key
factors for its growing use in MB, even though its long-term
results remain unclear (20)
In this scenario, adequate identification of MB with
hemodynamic relevance is of paramount importance to
avoid unnecessary interventions. As in fixed stenoses, intra-
coronary physiology techniques might constitute a valuable
alternative to coronary angiography (21), hampered as a
diagnostic tool by the complex hemodynamics, cyclic
changes in luminal dimensions and noncircular lumen
morphology. Furthermore, because they are dynamic steno-
ses dependent on the degree of extravascular compression
and intramyocardial tension (22,23), their invasive assess-
ment should not be limited to rest conditions, which might
leave unidentified the hemodynamic relevance of MB only
during exercise or situations of increased inotropism.
We report our experience of angiographic and physio-
logic evaluation of MB using pressure guide wires and
dobutamine challenge. Two pressure-derived indexes of
coronary reserve were obtained and compared: conventional
fractional flow reserve (FFR) calculated from mean pres-
sures over the complete cardiac cycle (24), and diastolic FFR
calculated from diastolic pressures only (25). Dobutamine
was chosen as the inotropic challenge because it is compat-
ible with FFR studies (26). Finally, diastolic FFR was
compared with mean FFR because intracoronary systolic
pressure overshooting occurs in MB (9,19) and potentially
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could interfere with measurements based on mean pressures.
The study was not designed as a validation against non-
invasive tests for detection of ischemia, and its aim was the
comparison of two already validated intracoronary physiol-
ogy indices.
METHODS
Study population. We studied 12 patients with angina in
whom the only relevant angiographic finding was a com-
pression of the mid segment of the left anterior coronary
artery by an MB causing a50% reduction in systolic vessel
diameter, as visually assessed. All patients had abnormal
noninvasive tests and/or electrocardiogram (ECG) changes
during or immediately prior to admission that were sugges-
tive of myocardial ischemia. None of the patients presented
concomitant coronary stenoses or any present or previous
cardiac events. Echocardiography ruled out concomitant
hypertrophic cardiomyopathy in all patients. Informed con-
sent to catheterization and physiologic assessment was
obtained in all patients. Demographic data, including age,
gender, and cardiovascular risk factors, were recorded.
Catheterization procedure. Beta-blockers were inter-
rupted five days prior to cardiac catheterization in two
patients receiving these drugs. A right femoral artery ap-
proach was used. After administration of 5,000 IU of
unfractioned heparin and 200 g of intracoronary nitroglyc-
erin, baseline coronary angiograms were obtained in several
angiographic views. The two views showing a better visu-
alization of the MB were chosen for further angiographic
runs, which were performed at a speed of 25 frames/s for
detailed analysis of systolic coronary compression.
Translesional pressure measurements. Aortic pressure
was obtained by using a 6F to 8F guiding catheter without
side holes, connected to a pressure transducer (B/Braun,
Braun, Melsunger, Germany) and to a Horizon 9000
computerized polygraph (Horizon 9000, Mennen Medical
Inc., Haifa, Israel). After calibration, a 0.014-inch
micromanometer-tipped guide wire (PressureWire, Radi
Medical Systems, Uppsala, Sweden) connected to its interface
and to the polygraph was advanced under fluoroscopy, distal to
the MB. The pressure sensor was located approximately 3 cm
distal to the MB in order to avoid its entrapment and direct
compression by the bridge. Selected pressure tracings and
angiographic runs were recorded during this procedure accord-
ing to the following scheme.
1. Baseline measurements. Following intracoronary adminis-
tration of 200 g of nitroglycerin, baseline pressure
measurements were obtained during hyperemia induced
by a 20g intracoronary adenosine bolus. Coronary
angiography was then performed.
2. Measurements during dobutamine challenge. Intravenous
infusion of 5 g/kg/min dobutamine was given for 5
min. Then, after a bolus of 100 g of nitroglycerin, a
new set of pressure measurements were performed dur-
ing hyperemia, repeating a 20 g intracoronary adeno-
sine bolus. Coronary angiography was then repeated to
document changes in the severity of systolic vessel
compression. Dobutamine was then increased in 5 g/
kg/min doses, and identical sets of measurements, as
described here, were repeated after 5 min. This scheme
was repeated until a maximum dose of 20 g/kg/min
dobutamine was reached or until the patient developed
symptoms. Because it is the first study, to our knowledge,
to combine intracoronary instrumentation of MB and
enhanced inotropism, higher doses of dobutamine were
not intended as a precaution. At the end of the proce-
dure, the persistence of the guide wire calibration was
checked.
Digital acquisition and post-processing of physiologic
data. Continuous digital acquisition and storage of the
ECG, aortic, and intracoronary pressures were performed
using a 12-bit resolution analog-to-digital converter (DI-
200 PGL, DataQ Instruments, Akron, Ohio) controlled by
dedicated software (WinDaq 200, DataQ Instruments) in a
personal computer. The sampling rate was 114 Hz per
channel. After the procedure, off-line analysis was per-
formed using the WinDaq and Advanced Codas software
(DataQ Instruments), allowing the calculation and display
of instantaneous pressure gradients as waveforms. Relevant
data intervals were selected and transferred to a Macintosh
Power PC 8500 computer for further statistical analysis
(StatView 5.0, SAS Institute Inc., Cary, North Carolina).
All measurements were performed during maximal hy-
peremia, which was identified as the interval with a peak
instantaneous pressure gradient (P) across the MB after
adenosine administration. Diastole was identified as the
interval between the dichrotic notch in the aortic pressure
tracing and the following R-wave peak in the ECG.
Average (mean) and diastolic components of aortic pressure
(Pa), distal intracoronary pressure (Pd), and P were
calculated.
Estimation of FFR. Fractional flow reserve was defined as
the ratio between pressures measured distal to and proximal
to the MB during maximal hyperemia. For study purposes,
two indexes of FFR were used. Conventional FFR was
calculated using mean or average pressures during the whole
cardiac cycle (mean FFR  mean Pd/mean Pa) (24). The
cutoff point of 0.75, with reported sensitivity and specificity
of 88% and 100%, respectively (25), was used to detect
hemodynamic relevance. Diastolic FFR was calculated using
Abbreviations and Acronyms
%DS  percent diameter stenosis
ECG  electrocardiogram
FFR  fractional flow reserve
MB  myocardial bridges
P  pressure gradient
Pa  aortic pressure
Pd  distal intracoronary pressure
227JACC Vol. 42, No. 2, 2003 Escaned et al.
July 16, 2003:226–33 Physiologic Assessment of Myocardial Bridging
only diastolic pressures. The cutoff value of 0.76 for the
detection of hemodynamic relevance in the left anterior
descending artery, with reported sensitivity and specificity of
96% and 100%, respectively (25), was used.
Quantitative coronary angiography. Cineangiographic
frames were analyzed using an automated edge-detection
quantitative angiography system (QCA-CMS Medical Im-
aging Systems, Leiden, The Netherlands). The filmed
catheter tip was used as a scaling device. Measurements
were performed at the point of maximal systolic coronary
compression by the MB at baseline and at the end of each
stage of dobutamine challenge. Bifurcations were used as
landmarks for segment analysis. Edge detection was auto-
matically detected using the gradient field transform feature
included in the QCA-CMS for vessels with irregular
intraluminal morphology. From the diameter function ob-
tained by the system, the interpolated reference diameter,
minimal luminal diameter, stenosis length (mm), and per-
cent diameter stenosis (%DS) were calculated.
Statistical analysis. For all continuous variables, mean and
standard deviation were calculated. Linear regression anal-
ysis was performed using a least-square approach. Compar-
ison of mean values was performed using Student’s t test
(pair or unpaired, as required) or one-way analysis of
variance. For comparison of percentages in discrete variables
the chi-squared test was performed. A p value of 0.05 was
considered significant.
RESULTS
The study population was composed of 12 patients with an
age of 53  13 years, 11 (91%) were male, 3 (25%)
presented diabetes mellitus, 3 (25%) hypercholesterolemia,
4 (33%) systemic hypertension, and 5 (42%) had a history of
smoking. Nine patients presented an abnormal noninvasive
test suggesting myocardial ischemia (seven by means of
exercise tolerance test, two by means of MIBI SPECT).
The remaining three patients were admitted with unstable
angina and reversible ECG changes suggestive of anterior
wall myocardial ischemia. The study was successfully ac-
complished according to the protocol described earlier in all
patients without complications. In four patients the target
dose of dobutamine (20 g/kg/min) was reached. In five
patients dobutamine infusion was prematurely interrupted
due to chest pain that was described as being similar to
previous episodes, and in three due to anxiety and discom-
fort judged to be unbearable by the patient.
Angiographic findings. Figure 1 shows the effect of do-
butamine challenge on the angiographic features of MB.
Systolic %DS increased from 46.09  10.50 to 68.72 
17.95 (p  0.0001), and systolic minimal luminal diameter
decreased from 1.52  0.39 to 0.82  0.44 mm (p 
0.001). A twofold increase in stenosis length, as automati-
cally quantified by the quantitative angiography system,
occurred after dobutamine challenge: at baseline the com-
pressed segment was 12.40 9.05 mm in length, increasing
to 24.04 9.17 mm in length in response to dobutamine (p
 0.0005) (Figs. 1 and 2).
Hemodynamic changes. Dobutamine infusion caused an
increase in the double product from 8,884  2,239 at
baseline to 13,788  3,287 at the maximal dose reached (p
 0.0001). Hyperemic mean pressure gradient through the
MB was 8.93  4.90 mm Hg at baseline, reaching a
maximum of 13.89  8.35 mm Hg during dobutamine
challenge (p  0.06). The hyperemic systolic gradient
through the bridged segment was 6.40  4.81 mm Hg and
5.13  7.47 mm Hg at baseline and during dobutamine
challenge, respectively (p  NS). In six patients (50%), the
systolic gradient decreased in response to dobutamine infu-
sion, and in four (33%) it reached negative values, meaning
that as a result of the compressive effect of the MB on the
vessel, during systole the average coronary pressure distal to
the MB was higher than the aortic pressure (Fig. 3). During
diastole, a significant increase in pressure gradient through
the bridged segment was observed in response to dobut-
Figure 1. Angiographic characteristics of systolic vessel compression at baseline and at peak dobutamine challenge.
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amine infusion (increasing from 9.69  5.16 mm to 17.26
 8.53 mm Hg, p  0.002). When displayed as a
waveform, the instantaneous diastolic gradient typically
followed a peak-and-plateau morphology that closely re-
sembled a characteristic flow pattern documented by Dopp-
ler guide wires in MB by other authors (1,7–9,14,27) (Fig.
3), with a predominant early diastolic pressure gradient.
Before dobutamine mean FFR was 0.90  0.04, in all
cases higher than the cutoff value of 0.75 used with this
technique. Although mean FFR significantly decreased to
0.84  0.06 during dobutamine challenge (p  0.0008),
only one patient presented an FFR0.75 (Fig. 4). Diastolic
FFR was 0.88  0.05 and 0.77  0.10 at baseline and in
response to dobutamine infusion, respectively (p  0.0006).
Conversely, to mean FFR, a diastolic FFR value of 0.76
was already documented in one patient at baseline, and in
five patients during dobutamine infusion (Fig. 4). The MB
with associated diastolic FFR 0.76 presented a higher
angiographic severity in response to dobutamine challenge
(minimal luminal diameter 0.59  0.11 mm, %DS 74.00 
18.18%) than those with associated diastolic FFR 0.76
(minimal luminal diameter 0.98  0.21 mm, %DS 64.33 
18.14%), although these differences were not statistically
significant. A higher rate-pressure product was reached by
patients with diastolic FFR 0.76 than by those with
diastolic FFR 0.76 (16,413  1,586 vs. 11,914  2,879
mmHg·s, respectively, p  0.01). At baseline three of the
patients with diastolic FFR 0.76 had unstable angina and
reversible ECG changes suggestive of anterior wall myocar-
dial ischemia, and two had positive exercise tolerance tests.
The discrepancy between FFR based on mean as opposed
to diastolic pressures was expressed as the ratio of mean
FFR to diastolic FFR. This ratio increased significantly
from 1.03 0.02 at baseline 1.09  0.09 during dobut-
amine challenge (p  0.02). Because the difference between
diastolic and mean FFR is related to systolic events, the
relationship between the ratio of mean FFR to diastolic
FFR and the pressure gradient documented during systole
was investigated using linear regression analysis (Fig. 5). A
significant inverse relationship between the systolic gradi-
ents and diastolic FFR overestimation, absent at baseline,
developed during dobutamine challenge. This finding indi-
cates that the decrease or negativization of the systolic
pressure gradient across the MB was a major determinant of
the discrepancies between the two methods, contributing to
the inability of mean FFR to identify an MB in which the
ischemic threshold had been reached according to diastolic
FFR criteria.
Based on the lack of evidence concerning the long-term
outcome of stenting in the presence of an MB at the time of
inclusion in the study, long-term treatment with beta-
blockers was followed in all patients with hemodynamic
relevance of MB. At one year clinical follow-up, all these
patients remained asymptomatic and free of cardiac events.
DISCUSSION
The main conclusions of this study are: 1) the angiographic
and functional severity of some MB are demonstrated only
after inotropic stimulation; 2) the development of signifi-
cant diastolic pressure gradients demonstrates that MB
influence diastolic hemodynamics; 3) diastolic FFR identi-
fies a significant proportion of hemodynamically relevant
MB that are left unidentified by conventional FFR; and 4)
the superiority of diastolic FFR over conventional FFR
relies on the exclusion of systolic pressure gradients, char-
Figure 2. Modifications introduced by dobutamine challenge in the angiographic severity of left anterior descending myocardial bridging. With dobutamine
challenge, systolic minimal luminal diameter decreased from 0.75 to 0.35 mm, and the length of the compressed segment increased from 23.65 to 36.91
mm.
229JACC Vol. 42, No. 2, 2003 Escaned et al.
July 16, 2003:226–33 Physiologic Assessment of Myocardial Bridging
acteristic of MB hemodynamics. These aspects and their
implications are discussed in detail in the following para-
graphs.
Although angiographic evidence of MB is accepted as a
harmless variant of normal human coronary circulation (1),
a potential link between MB and various coronary syn-
dromes (1–6) has been strengthened by direct demonstra-
tion, using intracoronary techniques, of decreased coronary
flow reserve (7–10,14,19,27–30). These data have also
revealed two hemodynamic features that are specific to MB
Figure 3. Intracoronary hyperemic pressure measurements at baseline and during dobutamine challenge. The graph shows the recorded electrocardiogram
(EKG), aortic pressure (Pa), and intracoronary pressure distal to the myocardial bridge (Pd) as well as the instantaneous pressure gradient resulting from
the difference between the two pressures. These tracings are shown as recorded at baseline and during dobutamine challenge (note the differing scaling of
the pressure tracings). The overshooting of Pd over Pa noted during dobutamine challenge contributes to the characteristic negative systolic and positive
protodiastolic pressure gradients, which mimic the Doppler flow velocity pattern described previously (1,9). At baseline mean fractional flow reserve (FFR)
was 0.90 and diastolic FFR was 0.87; during dobutamine challenge mean FFR was 0.80 and diastolic FFR was 0.72.
Figure 4. Fractional flow reserve (FFR) values obtained at baseline and at peak dobutamine challenge using either mean or diastolic FFR. The combination
of dobutamine challenge and diastolic FFR allows identification of the largest number of patients in whom the optimal cutoff value for detection of
hemodynamic relevance was reached.
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and not present in fixed stenoses and that have relevance to
our study. First, the “milking” of blood in the compressed
epicardial segment against a highly resistive microcircula-
tion (systole) causes premature overshooting of intracoro-
nary over aortic pressure, resulting in a negative systolic
pressure gradient across the MB (9,19). Second, systolic
MB compression is followed by a delayed gain in luminal
dimensions during early diastole, which may impair dia-
stolic blood flow (8,30).
Because MB are dynamic stenoses, we believe that their
assessment should not be limited to a baseline situation but
should also include inotropic challenge. Intravenous dobut-
amine was used in this study because along with the positive
inotropic-effect increases coronary blood flow it causes (31),
it does not modify epicardial vessel or stenotic dimensions
(32), and it facilitates maximal coronary hyperemia (32). An
intermediate dose (20 g/kg/min) was used for safety
reasons and to limit its effect to increasing extravascular
compression (33), not aimed to induce the heterogeneity of
coronary flow, as in noninvasive imaging tests.
Furthermore, unlike coronary flow velocity reserve,
pressure-derived FFR is not influenced by dobutamine
administration (26,32). The widespread acceptance of FFR
also means that it is easy to perform, requiring only two
mean pressures to be obtained during maximal hyperemia
(24). Although the use of mean pressure constitutes a major
simplification of the shifting hemodynamics during the
cardiac cycle, the introduction of diastolic FFR and its
elegant validation by Abe et al. (25) supports the idea that
in fixed stenoses, the difference between mean and diastolic
values is not significant. However, for the study of MB,
diastolic FFR presents two theoretical advantages over
conventional FFR. First, the restriction of measurements to
diastole avoids the influence of systolic negative intracoro-
nary gradients on overall pressure measurements (9,19).
Second, it allows identification and quantification of the
effect of the MB on the diastolic coronary blood flow.
Our results demonstrate the usefulness and safety of
combining dobutamine challenge with diast FFR in the
presence of MB. At baseline, only one patient was found to
have a hemodynamically significant MB using diastolic
FFR. During dobutamine challenge, five patients were
identified by diastolic FFR and only one by conventional
FFR. As shown in Figure 5, the discrepancy between the
two FFR modalities is related to the inclusion of systolic
translesional gradients in conventional FFR and to increase
during dobutamine challenge. Therefore, when using con-
ventional FFR, a negative result, even after dobutamine
challenge, does not preclude the possibility of a false
negative, and should be interpreted with caution.
We found that a relationship between the degree of
inotropic stimulation and the degree of positivity of the test
might exist, because the patients who registered a diastolic
FFR 0.76 were found to have reached a higher rate-
pressure product than the others. Based on our results,
higher doses of dobutamine should be encouraged in future
studies in clinical practice if diastolic FFR remains 0.76
with intermediate doses of dobutamine. It is foreseeable that
Figure 5. Influence of the intracoronary systolic pressure gradients on the discrepancy between mean and diastolic fractional flow reserve (FFR)
measurements, expressed as the ratio mean FFR/diastolic FFR. At baseline the discrepancy between the techniques is minimal and is not influenced by
systolic gradients. Conversely, during dobutamine challenge a significant inverse relationship between intracoronary systolic gradient and the defined
discrepancy develops, being maximal in those patients who developed negative systolic intracoronary pressure gradients.
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even at higher doses of dobutamine, diastolic FFR will
remain a more sensitive technique than conventional FFR
for the detection of hemodynamic relevance. Although
calculation of diastolic FFR is currently cumbersome, the
development and implementation of algorithms for its
automatic calculation in pressure guide wire interfaces is
technically feasible and might be fostered by our results.
In agreement with Diefenbach et al. (22), we found that
the angiographic severity of MB is modified by dobutamine.
However, as has been documented in cases of fixed stenoses
(21), the angiographic severity of MB did not correlate well
with its functional relevance. If treatment by coronary
stenting is planned, dobutamine challenge may help in
sizing the stent length so as to avoid incomplete coverage of
the MB, which can be hazardous (16,34,35). The length of
the compressed segment may also provide clues to the
anatomic characteristics of the MB. In our population, the
mean length (24.04 mm) was found to fall between that of
the more commonly observed superficial, and potentially
harmless, bridges found in necropsy studies (15.3 mm) (36)
and that of the less common, deep MB (39.5 mm), which
theoretically may cause significant vessel compression or
twist (36).
Study limitations. This study was not designed for com-
parison of FFR with noninvasive tests in the detection of
ischemia. The performance of an intracoronary study to
ascertain the physiologic relevance of the MB was deemed
justified only in the presence of abnormal noninvasive tests
or chest pain with reversible ECG changes, so patients with
no evidence of ischemia were excluded. In those who
showed no documented pathologic FFR, the results of
noninvasive tests might be regarded as being false positive
or, as discussed earlier, as being a failure to reach a maximal
rate-pressure product. The observations obtained in this
regard will facilitate the performance of future studies.
Although intravenous administration of adenosine may be
superior to intracoronary administration, maximal coronary
hyperemia was also facilitated by the hyperemic effect of
dobutamine in our study (32).
Acknowledgment
The linguistic review and valuable comments of Dominick
Angiolillo, MD, during the preparation of this manuscript
are gratefully acknowledged.
Reprint requests and correspondence: Dr. Javier Escaned, Ser-
vicio de Cardiologia Intervencionista, Hospital Clinico San Carlos,
28040, Madrid, Spain. E-mail: jescaned.hcsc@salud.madrid.org.
REFERENCES
1. Bourassa MG, Butnaru A, Lesperance J, Tardif JC. Symptomatic
myocardial bridges: overview of ischemic mechanisms and current
diagnostic and treatment strategies. J Am Coll Cardiol 2003;41:351–9.
2. Angelini P, Trivellato M, Donis J, Leachman D. Myocardial bridges:
a review. Progress Cardiovasc Dis 1983;26:75–88.
3. Virmani R, Farb A, Burke AP. Ischemia from myocardial bridging:
fact or fancy? Hum Pathol 1993;24:687–8.
4. Tauth J, Sullebarger T. Myocardial infarction associated with myocar-
dial bridging: case history and review of the literature. Cathet Cardio-
vasc Diagn 1997;40:364–7.
5. Desseigne P, Tabib A, Loire R. Myocardial bridging on the left
anterior descending coronary artery and sudden death: apropos of 19
cases with autopsy (French). Arch Mal Coeur Vais 1991;84:511–6.
6. Pichard AD, Casanegra P, Marchant E, Rodriguez JA. Abnormal
regional myocardial flow in myocardial bridging of the left anterior
descending coronary artery. Am J Cardiol 1981;47:978–82.
7. Schwartz ER, Klues HG, von Dhal J, Klein I, Krebs W, Hanrath P.
Functional, angiographic and intracoronary Doppler flow characteris-
tics in symptomatic patients with myocardial bridging: effect of
short-term intravenous beta-blocker medication. J Am Coll Cardiol
1996;27:1637–45.
8. Schwartz ER, Klues HG, von Dhal J, Klein I, Krebs W, Hanrath P.
Functional characteristics of myocardial bridging. A combined angio-
graphic and intracoronary Doppler flow study. Eur Heart J 1997;18:
434–42.
9. Klues HG, Schwartz ER, von Dahl J, et al. Disturbed intracoronary
hemodynamics in myocardial bridging. Early normalization by intra-
coronary stent placement. Circulation 1997;96:2905–13.
10. Ge J, Jeremias A, Rupp A, et al. New signs characteristic of myocardial
bridging demonstrated by intracoronary ultrasound and Doppler. Eur
Heart J 1999;20:1707–16.
11. Kuhn FE, Reagan K, Mohler ER 3rd, Satler LF, Lu DY, Rackley CE.
Evidence for endothelial dysfunction and enhanced vasoconstriction in
myocardial bridges. Am Heart J 1991;122:1764–6.
12. Katznelson Y, Petchenko P, Knobel B, Cohen AJ, Kishon Y,
Schachner A. Myocardial bridging: surgical technique and operative
results. Mil Med 1996;161:248–50.
13. Stables RH, Knoght CJ, McNeill JG, et al. Coronary stenting in the
management of myocardial ischemia caused by muscle bridging. Br
Heart J 1995;74:90–2.
14. Akilli A, Kultursay H, Akin M, et al. Stenting of myocardial bridging.
J Invas Cardiol 1997;9:529–33.
15. Smith SC, Taber MT, Robiolio PA, et al. Acute myocardial infarction
caused by a myocardial bridge treated with intracoronary stenting.
Cathet Cardiovasc Diagn 1997;42:209–12.
16. Hering D, Horstkotte D, Schwimmbeck P, et al. Acute myocardial
infarction caused by a muscle bridge of the anterior interventricular
ramus: complicated course with vascular perforation after stent im-
plantation. Z Kardiol 1997;86:630–8.
17. Rzezniczak J, Angerer D, Kalawski R, et al. Intracoronary stent
implantation for treatment of myocardial ischemia induced by a
myocardial bridge: a case report. Kardiol Pol 1998;48:521.
18. Bayes A, Marti V, Auge JM. Coronary stenting for symptomatic
myocardial bridging. Heart 1998;80:102–3.
19. Prendergast BD, Kerr F, Starkey IR. Normalization of abnormal
coronary fractional flow reserve associated with myocardial bridging
using an intracoronary stent. Heart 2000;83:705–7.
20. Haager PK, Schwartz ER, von Dahl J, Reffelman T, Hanrath P. Long
term angiographic follow up in patients with stent implantation for
symptomatic myocardial bridging. Heart 2000;84:403–8.
21. Kern MJ. Coronary physiology revisited: practical insights from the
cardiac catheterization laboratory. Circulation 2000;101:1344–51.
22. Diefenbach C, Erbel R, Treese N, Bollenbach E, Meyer J. Incidence
of myocardial bridges after adrenergic stimulation and decreasing
afterload in patients with angina pectoris, but normal coronary arteries.
Z Kardiol 1994;83:809–15.
23. Carvalho VB, Macruz R, De´court LV, et al. Hemodynamic determi-
nants of coronary constriction in human myocardial bridges. Am
Heart J 1984;108:73–80.
24. Pijls NHJ, de Bruyne B, Peels K, et al. Measurement of myocardial
fractional flow reserve to assess the functional severity of coronary-
artery stenoses. N Engl J Med 1996;334:1703–8.
25. Abe M, Tomiyama H, Yoshida H, Doba N. Diastolic fractional flow
reserve to assess the functional severity of moderate coronary stenoses.
Comparison with fractional flow reserve and coronary flow velocity
reserve. Circulation 2000;102:2365–70.
26. De Bruyne B, Bartunek J, Sys SU, Pijls NH, Heyndrinckx GR, Wijns
W. Simultaneous coronary pressure and flow velocity measurements in
humans: feasibility, reproducibility and hemodynamic dependence of
coronary flow velocity reserve, hyperemic flow versus pressure slope
index, and fractional flow reserve. Circulation 1996;94:1842–9.
232 Escaned et al. JACC Vol. 42, No. 2, 2003
Physiologic Assessment of Myocardial Bridging July 16, 2003:226–33
27. Ge J, Erbel R, Gorge G, Haude M, Meyer J. High wall shear stress
proximal to myocardial bridging and atherosclerosis: intracoronary
ultrasound and pressure measurements. Br Heart J 1995;73:462–5.
28. Tio RA, Van Gelder IC, Boonstra PW, Crijns HJ. Myocardial
bridging in a survivor of sudden cardiac near-death: role of intracoro-
nary Doppler flow measurements and angiography during dobutamine
stress in the clinical evaluation. Heart 1997;77:280–2.
29. Kneale BJ, Stewart AJ, Coltart DJ. A case of myocardial bridging:
evaluation using intracoronary ultrasound, Doppler flow measurement,
and quantitative coronary angiography. Heart 1996;76:374–6.
30. Ge J, Erbel R, Rupprecht HJ, et al. Comparison of intravascular
ultrasound and angiography in the assessment of myocardial bridging.
Circulation 1994;89:1725–32.
31. Vatner SF, McRitchie RJ, Maroko PH, Patrick TA, Braunwald E.
Effects of catecholamines, exercise and nitroglycerin on the normal and
ischemic myocardium in conscious dogs. J Clin Invest 1974;54:563–75.
32. Bartunek J, Wijns W, Heyndrickx GR, de Bruyne B. Effects of
dobutamine on coronary stenosis physiology and morphology.
Comparison with intracoronary adenosine. Circulation 1999;100:
243–9.
33. Sonnenblick EH, Frishman WH, LeJemtel TH. Dobutamine: a new
synthetic cardioactive sympathetic amine. N Engl J Med 1979;300:
17–22.
34. Agirbasli M, Hillegass WB Jr, Chapman GD, Brott BC. Stent
procedure complicated by thrombus formation distal to the lesion
within a muscle bridge. Cathet Cardiovasc Diagn 1998;43:73–6.
35. Antonellis IP, Patsilinakos SP, Pamboukas CA, et al. Intracoronary
stent placement proximal to a myocardial bridge: immediate and
long-term results. Cathet Cardiovasc Interv 1999;46:363–7.
36. Ferreira AG, Trotter SE, Decourt LV, Olsen EGJ. Myocardial
bridges: morphological and functional aspects. Br Heart J 1991;66:
364–7.
233JACC Vol. 42, No. 2, 2003 Escaned et al.
July 16, 2003:226–33 Physiologic Assessment of Myocardial Bridging
